对乙酰氨基酚在全关节置换术中的疗效与安全性:系统综述与直接Meta分析
该研究系统检索MEDLINE、EMBASE和Cochrane对照试验中心注册库截至2019年9月的文献,评估口服与静脉对乙酰氨基酚在初次全关节置换术中的疗效与安全性。共严格评价1287篇文献,纳入17篇最佳证据进行分析;结果显示对乙酰氨基酚可安全减少住院期间术后疼痛与阿片类药物消耗。
要点
- 口服与静脉对乙酰氨基酚可在住院期间安全减轻术后疼痛并减少阿片类消耗。
- 中等证据支持其作为住院期间非阿片类辅助镇痛药使用。
- 出院后使用对乙酰氨基酚的疗效与安全性缺乏证据支持。
核心结论
- 中等证据支持口服和静脉对乙酰氨基酚作为住院期间疼痛管理的非阿片类辅助用药,强证据支持其在对初次全关节置换术患者适当给药时的安全性。
研究设计与样本
- 系统综述与直接Meta分析,检索MEDLINE、EMBASE和Cochrane对照试验中心注册库截至2019年9月前发表的文献,针对初次全关节置换术中应用对乙酰氨基酚的研究。
- 共严格评价1287篇文献,最终纳入17篇代表最佳可用证据的文献进行分析,所有纳入研究均经过定性与定量同质性检验。
主要发现
- 口服和静脉对乙酰氨基酚能够安全减少住院期间的术后疼痛和阿片类药物消耗。
- 没有证据可用于评估出院后口服对乙酰氨基酚的疗效与安全性。
关键数值与推荐
- 口服和静脉对乙酰氨基酚作为住院期间疼痛管理的非阿片类辅助用药获得中等证据支持。
- 口服和静脉对乙酰氨基酚在对初次全关节置换术患者适当给药时获得强证据支持其安全性。
临床怎么用
- 可将口服或静脉对乙酰氨基酚作为初次全关节置换术围手术期多模式镇痛方案的一部分用于住院期间。
- 出院后虽缺乏强证据,对乙酰氨基酚仍可作为多模式镇痛方案中低成本、低风险的选择。
局限性
- 缺乏评估出院后口服对乙酰氨基酚疗效与安全性的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oral and intravenous (IV) acetaminophen has become widely used perioperatively as part of a multi-modal pain management protocol for primary total joint arthroplasty (TJA). The purpose of our study is to evaluate the efficacy and safety of acetaminophen in support of the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Management. METHODS: We searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials for studies published prior to September 2019 on acetaminophen in primary TJA. All included studies underwent qualitative and quantitative homogeneity testing followed by a systematic review and direct comparison meta-analysis to assess the efficacy and safety of acetaminophen. RESULTS: In total, 1287 publications were critically appraised yielding 17 publications representing the best available evidence for analysis. Oral and IV acetaminophen demonstrates the ability to safely reduce postoperative pain and opioid consumption during the inpatient hospital stay. No evidence was available to assess the efficacy and safety of oral acetaminophen after discharge. CONCLUSION: Moderate evidence supports the use of oral and IV acetaminophen as a non-opioid adjunct for pain management during the inpatient hospitalization. Strong evidence supports the safety of oral and IV acetaminophen when appropriately administered to patients undergoing primary TJA. Although there is lack of robust evidence for use of acetaminophen following discharge, it remains a low-cost and low-risk option as part of a multimodal pain regimen.
引用
- Fillingham YA, Hannon CP, Erens GA, et al. The Efficacy and Safety of Acetaminophen in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis. J Arthroplasty. 2020. PMID: 32563592. doi:10.1016/j.arth.2020.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。